13F Data
13F filer · CIK 1601692

KOTLER KEVIN

MELVILLE, NY · filing since Q4 2025 · last filing Feb 17, 2026
Reported value
$427.5M
Positions
38
New / sold out
38 / 0
Added / reduced
0 / 0
Turnover
–
buys $427.5M · sells $0
Top-10 weight
89.6%

No 13F for Q3 2025, so every position this quarter shows as new.

Biggest buys vs Q3 2025

ChangeSecurityShares changeChange %Est. trade value
NewSPYSPDR S&P 500 ETF TRPUT+350,000–+$238.7M
NewINVESCO QQQ TRPUT+50,000–+$30.7M
NewANGIODYNAMICS INC+1,713,789–+$22.0M
NewAURINIA PHARMACEUTICALS INC+1,224,846–+$19.5M
NewAVADEL PHARMACEUTICALS PLCCALL+879,400–+$19.0M
NewAVADEL PHARMACEUTICALS PLC+741,343–+$16.0M
NewOMEROS CORP+905,635–+$15.6M
NewNEUROPACE INC+631,468–+$9.7M
NewMEDIWOUND LTD+337,236–+$6.2M
NewAXOGEN INC+168,000–+$5.5M
28 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q3 2025

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2025: $427.5M
Q4 2025Q4 2025

Holdings · Q4 2025

#SecuritySharesValueWeight
1SPYSPDR S&P 500 ETF TRPUT350,000$238.7M55.83%
2INVESCO QQQ TRPUTUNIT SER 150,000$30.7M7.18%
3ANGIODYNAMICS INCCOM1,713,789$22.0M5.15%
4AURINIA PHARMACEUTICALS INCCOM1,224,846$19.5M4.57%
5AVADEL PHARMACEUTICALS PLCCALLCOM SHS879,400$19.0M4.43%
6AVADEL PHARMACEUTICALS PLCCOM SHS741,343$16.0M3.74%
7OMEROS CORPCOM905,635$15.6M3.64%
8NEUROPACE INCCOM631,468$9.7M2.28%
9MEDIWOUND LTDSHS NEW337,236$6.2M1.46%
10AXOGEN INCCOM168,000$5.5M1.29%
28 more rows. Subscribe for $29/month to see every row, download the data and use the API.